U.S. Cosmetic Regulations and New Legislation

  • Speaker:NORMA SKOLNIK
  • Date: 28th April 2017 10:00 AM PST | 01:00 PM EST
  • Duration:75Min
  • Product Code:GRC-90119

$219

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

Description:

This webinar will cover laws and regulations for successful marketing and compliance of cosmetics in the U.S. It will help clarify what claims and product labeling are appropriate for cosmetics to market them successfully and avoid regulatory issues and problems with FDA compliance and competitive challenges. Current FDA Warning letters to cosmetic firms will be reviewed. Adverse Event Reporting requirements for cosmetics will be discussed with focus on how these requirements will change under newly proposed legislation for cosmetics: The Personal Care Products Safety Act.

Key Learning Objectives of Topic :

  • a. Key regulatory requirements for marketing cosmetics in the U.S.
  • b. FDA labeling requirements for cosmetics.
  • c. What cosmetic claims are appropriate for cosmetics vs. those to avoid.
  • d. FDA’s changing views on cosmetic enforcement.
  • e. Newly proposed legislation: The Personal Care Products Safety Act and how it will impact cosmetic regulatory requirements.
  • f. Serious Adverse Event reporting for cosmetics and how this will change.

Instructor Profile :

Norma Skolnik has over 35 years of U.S. regulatory experience, starting in the pharmaceutical industry. She was Associate Director of Regulatory Affairs at Lederle Laboratories in Pearl River, N.Y. and then became Associate Director of Regulatory Affairs at Lederle Consumer Health where she helped launch Centrum and Caltrate dietary supplements. When Lederle was acquired by Wyeth, she became Associate Director of Regulatory Affairs there, acquiring more experience in the Dietary Supplement and OTC drug fields. She joined Warner-Lambert Consumer Health division in 1998 and became Assistant Director of Adams Regulatory Affairs. In 2002 after Pfizer’s takeover of Warner-Lambert, she was promoted to Director of Regulatory Affairs for the Adams division. Adams was acquired by Cadbury-Schweppes in 2003 and she served as Cadbury Adams’ Director of Regulatory Affairs for the Americas from 2003 until her retirement in 2008.

Norma earned a Bachelor’s degree in Biology from the University of Cincinnati and holds a Master’s degree from Pratt Institute in Brooklyn, New York. She's also done graduate work at Columbia University and Montclair State University. Today Norma works as a regulatory consultant to FDA regulated companies and to firms who wish to launch products in the U.S.A

Available Options

Recording: Access it for 6 months from any location

$219

CD: Shipped within 2 working days

$349

5 Member Group: Access the Live Meeting online from any location globally

$889

10 Member group: Access the Live Meeting online from any location globally

$1,679

Recording: 24 Hour Access Only

$69
For discounts and offers call support

Related Products

Labelling of GMO’s in the USA

Labelling of GMO’s in the USA

Description : This event will offer an overview of the status of GMO’s/Genetically Engineered foods in the USA, how they are regulated by the FDA, FDA’s Biotechnology Policy and Consultation program, and GMO labeling regulations around the world. U.S. State, federal and consumer initiatives to require GMO food labeling in the USA will be discussed, including the soon to be enacted Vermont GMO Labeling law 120. Useful regulatory references will also be provided. Please provide key Learning Obje..

$209

FDA Regulation of OTC Drugs in the U.S

FDA Regulation of OTC Drugs in the U.S

Description : This webinar will cover laws and regulations for successful marketing and compliance of OTC Drugs in the USA. The presentation will provide an overview of FDA OTC Drug regulations with a focus on OTC Drug Labeling requirements. It will help the attendee understand basic regulatory requirements for marketing and labeling OTC drugs successfully in the USA. Objectives of Topic:a. To gain an understanding of current Regulatory requirements for marketing OTC drugs in the U.S...

$215

Adverse event Reporting for Cosmetics ,OTC Drugs & Dietary Supplements

Adverse event Reporting for Cosmetics ,OTC Drugs & Dietary Supplements

Description: This webinar will cover laws and regulations for Adverse Event Reporting of OTC Drugs, Dietary Supplements & Cosmetics in the U.S.A.  The presentation will provide an understanding of FDA regulations to determine what are serious adverse events and how to report them properly. It will help the attendee understand current regulatory requirements for OTC Drug and Dietary Supplement adverse event reporting and what’s ahead for Cosmetic reporting in the U.S.A.Objectives of..

$209